Eam Investors, LLC Voyager Therapeutics, Inc. Transaction History

Eam Investors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$6.94 - $13.99 $441,966 - $890,939	63,684 Added 51.43%	187,502 $2.15 Million
Q1 2023 Jul 12, 2023	BUY	$6.0 - $10.78 $702,336 - $1.26 Million	117,056 Added 1731.09%	123,818 $954,000
Q1 2023 May 12, 2023	BUY	$6.0 - $10.78 $40,572 - $72,894	6,762 New	6,762 $52,000
Q2 2022 Aug 12, 2022	SELL	$4.82 - $10.09 $1.64 Million - $3.43 Million	-339,497 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.75 - $9.44 $933,616 - $3.2 Million	339,497 New	339,497 $2.59 Million
Q3 2019 Nov 13, 2019	SELL	$16.31 - $28.29 $630,430 - $1.09 Million	-38,653 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $741,364 - $1.08 Million	38,653 New	38,653 $1.05 Million
Q2 2018 Aug 03, 2018	SELL	$16.76 - $23.92 $534,727 - $763,167	-31,905 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$16.16 - $31.31 $515,584 - $998,945	31,905 New	31,905 $599,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.